These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 809531)
21. Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection. Suresh MV; Singh SK; Ferguson DA; Agrawal A J Immunol; 2006 Apr; 176(7):4369-74. PubMed ID: 16547275 [TBL] [Abstract][Full Text] [Related]
22. C-reactive protein and natural IgM antibodies are activators of complement in a rat model of intestinal ischemia and reperfusion. Padilla ND; van Vliet AK; Schoots IG; Valls Seron M; Maas MA; Peltenburg EE; de Vries A; Niessen HW; Hack CE; van Gulik TM Surgery; 2007 Nov; 142(5):722-33. PubMed ID: 17981193 [TBL] [Abstract][Full Text] [Related]
23. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis. Holzer TJ; Edwards KM; Gewurz H; Mold C J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291 [TBL] [Abstract][Full Text] [Related]
24. Effect of basic polycations and proteins on purified insulin receptor. Insulin-independent activation of the receptor tyrosine-specific protein kinase by poly(L-lysine). Fujita-Yamaguchi Y; Sacks DB; McDonald JM; Sahal D; Kathuria S Biochem J; 1989 Nov; 263(3):813-22. PubMed ID: 2557012 [TBL] [Abstract][Full Text] [Related]
25. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen. Fiedel BA; Gewurz H J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942 [TBL] [Abstract][Full Text] [Related]
26. Endothelial functional responses and increased vascular permeability induced by polycations. Needham L; Hellewell PG; Williams TJ; Gordon JL Lab Invest; 1988 Oct; 59(4):538-48. PubMed ID: 2459501 [TBL] [Abstract][Full Text] [Related]
27. Complement activation by C-reactive protein on the HEp-2 cell substrate. Vaith P; Prasauskas V; Potempa LA; Peter HH Int Arch Allergy Immunol; 1996 Oct; 111(2):107-17. PubMed ID: 8859218 [TBL] [Abstract][Full Text] [Related]
28. Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity. Venge P; Olsson I J Immunol; 1975 Dec; 115(6):1505-8. PubMed ID: 1184964 [TBL] [Abstract][Full Text] [Related]
29. Studies on the interactions between C-reactive protein and complement proteins. Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159 [TBL] [Abstract][Full Text] [Related]
30. Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis. Mortensen RF; Osmand AP; Lint TF; Gewurz H J Immunol; 1976 Sep; 117(3):774-81. PubMed ID: 60448 [TBL] [Abstract][Full Text] [Related]
31. Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine. McLeod B; Baker P; Behrends C; Gewurz H Immunology; 1975 Feb; 28(2):379-90. PubMed ID: 47309 [TBL] [Abstract][Full Text] [Related]
32. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro. Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695 [TBL] [Abstract][Full Text] [Related]
33. Complement activation induced by human C-reactive protein in mildly acidic conditions. Miyazawa K; Inoue K J Immunol; 1990 Jul; 145(2):650-4. PubMed ID: 2365997 [TBL] [Abstract][Full Text] [Related]
34. Monomeric C-reactive protein inhibits renal cell-directed complement activation mediated by properdin. O'Flynn J; van der Pol P; Dixon KO; Prohászka Z; Daha MR; van Kooten C Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1308-16. PubMed ID: 26984957 [TBL] [Abstract][Full Text] [Related]
35. Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system. Jiang H; Lint TF; Gewurz H Immunology; 1991 Dec; 74(4):725-31. PubMed ID: 1783430 [TBL] [Abstract][Full Text] [Related]
36. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain. Jiang H; Robey FA; Gewurz H J Exp Med; 1992 May; 175(5):1373-9. PubMed ID: 1569403 [TBL] [Abstract][Full Text] [Related]
37. Complement and leukocyte independent proteinuria and eicosanoid synthesis in rat membranous nephropathy. Rahman MA; Liu CN; Dunn MJ; Emancipator SN Lab Invest; 1988 Oct; 59(4):477-83. PubMed ID: 3050273 [TBL] [Abstract][Full Text] [Related]
38. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. Jiang HX; Siegel JN; Gewurz H J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402 [TBL] [Abstract][Full Text] [Related]
39. Biological effects of short-term, high-concentration exposure to methyl isocyanate. VI. In vitro and in vivo complement activation studies. Kolb WP; Savary JR; Troup CM; Dodd DE; Tamerius JD Environ Health Perspect; 1987 Jun; 72():189-95. PubMed ID: 3622434 [TBL] [Abstract][Full Text] [Related]
40. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family. Low PJ; Ai R; Ogata RT J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]